ACR Convergence 2025| Video: Rheum for Everyone, Episode 26—Ableism

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: pediatric

Mopic / shutterstock.com

Research Targets Interferon Alpha in New Treatment Approach for CNS Lupus

Mary Beth Nierengarten  |  November 9, 2017

RETRACTED Editor’s note: The study this article reported on was retracted by the researchers. Key aspects could not be replicated, and they said, “Most importantly, the findings from behaviour studies and sequencing of microglia isolated from 564Igi autoimmune mice as shown in Figs. 1a, b, d and 3a, b are not substantiated upon further analysis…

Filed under:ConditionsResearch RheumSystemic Lupus Erythematosus Tagged with:brain dysfunctioncentral nervous systemCNS lupusinterferon alphaLupusManagementneuropsychiatricpathologyResearchrheumatologyTreatment

Rheumatology Health Professionals’ Awards, Appointments and Announcements November 2017

Carol Patton  |  November 8, 2017

Dr. Sherine Gabriel Joins Board of Trustees In July, ACR Past President Sherine E. Gabriel, MD, MSc, joined the New York Academy of Medicine Board of Trustees. Dr. Gabriel is a distinguished professor and dean of Rutgers Robert Wood Johnson Medical School. As dean emerita of Mayo Medical School, Dr. Gabriel developed successful clinical research training and career development…

Filed under:Career DevelopmentProfessional TopicsResearch Rheum Tagged with:AwardsCareerProfilepromotionResearchrheumatologistrheumatology health professionals

crystal light / shutterstock.com

Rheumatology Case Report: Hand Abnormalities Feature of Fetal Hydantoin Syndrome

Reshma Khan, MD, & Andrew Evans, DO  |  November 6, 2017

Research has shown that anticonvulsants are teratogens and pose a risk for fetal malformations. Meadow was the first to note a possible link between congenital abnormalities and maternal use of anticonvulsive drug in 1968.1 In 1974, Barr et al noted hypoplasia and irregular ossification of the digital distal phalanges with nail dystrophy in children born to…

Filed under:ConditionsResearch Rheum Tagged with:anticonvulsive drugcase reportClinicaldistal limb deformityEpilepsyfetal hydnatoin syndromegenetic anomolyhand abnormalityMedicationoutcomepathologyResearchRheumatic Diseaserheumatologyrisk

Year in Review: The ACR Advances Education, Rheumatic Disease Awareness, Strategic Planning in 2017

Sharad Lakhanpal, MBBS, MD  |  November 5, 2017

It seems like yesterday I was asked to write my first presidential column, and here I am penning my last. It’s incredible how fast the time goes and yet how much gets done. That progress is made possible by the dedicated and talented group of ACR volunteers and staff. This year, the College has had…

Filed under:Patient PerspectiveResearch RheumWorkforce Tagged with:AC&RAffordable Care Act (ACA)American College of Rheumatology (ACR)AwarenessCDCCommittee on Rheumatologic Care (CORC)DatabasedrugEducationFDAgoalmissionResearchRheumatic DiseaserheumatologistRISETraining

One Member’s Personal Story Illustrates How RheumPAC Can Help Underserved Children

Brett Smith, DO  |  November 1, 2017

Almost one year into my term on the ACR’s Political Action Committee, RheumPAC, I’m looking back and reflecting on what led me here. My early career was focused on learning the basics of clinical practice and building relationships with healthcare providers. Shortly after I completed my fellowship, I established goals to improve access to care…

Filed under:Legislation & Advocacy Tagged with:caid programMIPSRheumPACTennCare

Tocilizumab a “First Choice” for PHID Syndrome

Reuters Staff  |  October 30, 2017

NEW YORK (Reuters Health)—Tocilizumab should be the “first choice” for treatment of the autoinflammatory and cutaneous manifestations of pigmentary hypertrichosis and non-autoimmune insulin-dependent diabetes mellitus (PHID) syndrome, say clinicians from the U.K. PHID syndrome is an extremely rare autosomal recessive genetic disease caused by mutations in the SLC29A3 gene. Children with the syndrome develop patches…

Filed under:ConditionsOther Rheumatic ConditionsPediatric Conditions Tagged with:ChildrenPediatricPHID syndrometocilizumab

New RheumPAC Investor Portal Unveiled

Harry L. Gewanter, MD, FAAP, FACR  |  October 19, 2017

This is my fifth year serving on RheumPAC, and some of the questions that I repeatedly have been asked include: Why can’t I divide my investments into automatic monthly payments? Why can’t I invest from my phone? Why can’t I schedule an annual contribution so I don’t forget to invest? Why can’t I look up…

Filed under:Legislation & Advocacy Tagged with:investor portalRheumPAC

futuristman / shutterstock.com

Fulbright Scholar Researches Physical Activity in Swedish Children with Juvenile Idiopathic Arthritis

Carina Stanton  |  October 18, 2017

A stroll through downtown Stockholm presents a quintessential picture of an active community, with most people biking or walking as their preferred mode of travel. Yet children in Sweden who live with juvenile idiopathic arthritis (JIA)—currently estimated at around 64 of every 100,000—don’t always engage in this active lifestyle.1 Maura Daly Iversen, PT, DPT, SD,…

Filed under:ConditionsPediatric ConditionsProfilesResearch Rheum Tagged with:Dr. Maura IversonFulbright ScholarshipJIAJuvenile idiopathic arthritispatient carePediatricphysical activityResearchrheumatologySweden

Rheumatology Health Professionals

Carol Patton with Ann-Marie Lindstrom  |  October 17, 2017

‘Living’ Pelvis in the Guinness Book of World Records Shashank Akerkar, MD, an ACR fellow and rheumatoid arthritis specialist at the Mumbai Arthritis Clinic and Research Center in India, found a unique way to draw attention to ankylosing spondylitis (AS). He persuaded 425 patients, mostly those suffering from AS or affected by lupus or rheumatoid…

Filed under:Career DevelopmentProfessional TopicsResearch Rheum Tagged with:AwardsCareerProfilepromotionResearchrheumatologistrheumatology health professionals

Advances in Precision Immunology Require Precision Controls to Further Research

Lara C. Pullen, PhD  |  October 17, 2017

CHICAGO—During the 2017 annual Federation of Clinical Immunology Societies (FOCIS) meeting, a session focused on precision immunology and its advances. Precision immunology describes the identification of host, immune system and tumor factors that can be used to select an immunotherapy approach. Thus, the first step in precision immunology is to identify soluble factors, immune cell…

Filed under:Meeting ReportsResearch Rheum Tagged with:ClinicalDiagnosisFederation of Clinical Immunology SocietiesFOCIS 2017Immunologyimmunotherapymeeting reportsoutcomePrecision MedicineRAResearchRheumatic DiseaseRheumatoid arthritisrheumatologytreatment approach

  • « Previous Page
  • 1
  • …
  • 67
  • 68
  • 69
  • 70
  • 71
  • …
  • 112
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences